Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Peter Fox; Bo Gao; Bavanthi Balakrishnar; Alexander M. Menzies; Shang Heng Yeap; Sayed Sahanawaz Ali; Val Gebski; Pamela Provan; Sally Coulter; Christopher Liddle; Rina Hui; Richard Kefford; Jodi Lynch; Nicholas Wilcken; Rosemary L. Balleine; Howard Gurney

doi:10.1200/jco.2013.31.15_suppl.543

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Peter Fox, Bo Gao, Bavanthi Balakrishnar, Alexander M. Menzies, Shang Heng Yeap, Sayed Sahanawaz Ali, Val Gebski, Pamela Provan, Sally Coulter, Christopher Liddle, Rina Hui, Richard Kefford, Jodi Lynch, Nicholas Wilcken, Rosemary L. Balleine, Howard Gurney

Research output: Contribution to journal › Meeting abstract › peer-review

25 Citations (Scopus)

Original language	English
Article number	543
Pages (from-to)	1-1
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	31
Issue number	15 supplement
DOIs	https://doi.org/10.1200/jco.2013.31.15_suppl.543
Publication status	Published - 20 May 2013
Externally published	Yes
Event	Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 31 May 2013 → 4 Jun 2013

Access to Document

10.1200/jco.2013.31.15_suppl.543

Cite this

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L., & Gurney, H. (2013). Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation. Journal of Clinical Oncology, 31(15 supplement), 1-1. Article 543. https://doi.org/10.1200/jco.2013.31.15_suppl.543

@article{f1a3e667f50047deb894a4ed40739f6f,

title = "Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation",

author = "Peter Fox and Bo Gao and Bavanthi Balakrishnar and Menzies, \{Alexander M.\} and Yeap, \{Shang Heng\} and Ali, \{Sayed Sahanawaz\} and Val Gebski and Pamela Provan and Sally Coulter and Christopher Liddle and Rina Hui and Richard Kefford and Jodi Lynch and Nicholas Wilcken and Balleine, \{Rosemary L.\} and Howard Gurney",

year = "2013",

month = may,

day = "20",

doi = "10.1200/jco.2013.31.15\_suppl.543",

language = "English",

volume = "31",

pages = "1--1",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15 supplement",

note = "Annual Meeting of the American Society of Clinical Oncology (ASCO) ; Conference date: 31-05-2013 Through 04-06-2013",

}

Fox, P, Gao, B, Balakrishnar, B, Menzies, AM, Yeap, SH, Ali, SS, Gebski, V, Provan, P, Coulter, S, Liddle, C, Hui, R, Kefford, R, Lynch, J, Wilcken, N, Balleine, RL & Gurney, H 2013, 'Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation', Journal of Clinical Oncology, vol. 31, no. 15 supplement, 543, pp. 1-1. https://doi.org/10.1200/jco.2013.31.15_suppl.543

TY - JOUR

T1 - Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

AU - Fox, Peter

AU - Gao, Bo

AU - Balakrishnar, Bavanthi

AU - Menzies, Alexander M.

AU - Yeap, Shang Heng

AU - Ali, Sayed Sahanawaz

AU - Gebski, Val

AU - Provan, Pamela

AU - Coulter, Sally

AU - Liddle, Christopher

AU - Hui, Rina

AU - Kefford, Richard

AU - Lynch, Jodi

AU - Wilcken, Nicholas

AU - Balleine, Rosemary L.

AU - Gurney, Howard

PY - 2013/5/20

Y1 - 2013/5/20

UR - https://www.scopus.com/pages/publications/84871780523

U2 - 10.1200/jco.2013.31.15_suppl.543

DO - 10.1200/jco.2013.31.15_suppl.543

M3 - Meeting abstract

SN - 0732-183X

VL - 31

SP - 1

EP - 1

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15 supplement

M1 - 543

T2 - Annual Meeting of the American Society of Clinical Oncology (ASCO)

Y2 - 31 May 2013 through 4 June 2013

ER -

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Access to Document

Other files and links

Cite this